Vimarsana
Biggest News Aggregation in the World

Page 12 - Array Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Array Biopharma Today - Breaking & Trending Today

Acrivon cuts IPO price to raise $99M for plan to revive old Lilly cancer drug - Vimarsana News

Acrivon cuts IPO price to raise $99M for plan to revive old Lilly cancer drug

BioPharma

Kymera Therapeutics Appoints Biopharmaceutical Leader Victor Sandor, M.D.C.M., to Board of Directors - Vimarsana News

Kymera Therapeutics Appoints Biopharmaceutical Leader Victor Sandor, M.D.C.M., to Board of Directors

WATERTOWN, Mass., Nov. 03, 2022 -- Kymera Therapeutics, Inc. , a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader... | November 3, 2022

Kymera Therapeutics Appoints Biopharmaceutical Leader - Vimarsana News

Kymera Therapeutics Appoints Biopharmaceutical Leader

WATERTOWN, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing...

A startup plans an IPO to give a shelved Lilly drug another shot - Vimarsana News

A startup plans an IPO to give a shelved Lilly drug another shot

BioPharma

DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations - Vimarsana News

DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations

Leadership Team Continues to Expand with Addition of Key Leader in Clinical OperationsMINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appoint...